Pictet Asset Management Sa Chemo Centryx, Inc. Transaction History

Pictet Asset Management Sa

  • $83.4 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$22.17 - $51.8 $52.5 Million - $123 Million
-2,368,745 Reduced 99.84%
3,900 $201,000
Q2 2022

Aug 09, 2022
BUY
$15.36 - $27.51 $8.18 Million - $14.6 Million
532,478 Added 28.94%
2,372,645 $58.8 Million
Q1 2022

May 13, 2022
BUY
$22.22 - $39.12 $5.22 Million - $9.18 Million
234,758 Added 14.62%
1,840,167 $46.1 Million
Q4 2021

Feb 10, 2022
BUY
$18.38 - $40.5 $29.5 Million - $65 Million
1,605,409 New
1,605,409 $58.5 Million

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email